評論
打印
Three in every four of responding Boots pharmacists believe that the cuts imposed by their employer,
在接受調查的博姿藥劑師中，有四分之三的人認為，雇主實施的裁員，
whether the drop in staff numbers or increased workloads, threaten patient safety at least half the time or more.
無論是工作人員數量的減少還是工作量的增加，至少有一半或更多的時間威脅到患者的安全。
In response, Boots points out that it now employs more than 6,000 pharmacists in the UK, up from about 4,500 before the buyout.
作為回應，博姿指出，該公司目前在英國擁有6000多名藥劑師，高于收購前的4500名左右。
However, that rise tracks the increase in its number of stores, up from 1,400 in 2005 to around 2,400 today.
不過，其門店數量也有一樣的增長趨勢，從2005年的1400家增至如今的2400家左右。
I asked Boots what had happened to the number of dedicated pharmacy support staff,
我問博姿，專門的藥房支持人員的數量怎么了，
the dispensers and assistants that Boots chemists reported they were having to do without. The company did not respond.
博姿藥劑師報告說，他們不得不放棄配藥員和助手。該公司沒有回應。
Asked what dangers these cuts might pose to patients, John Murphy, general secretary of the PDA,
當被問及這些削減會給病人帶來什么危險時，PDA的秘書長約翰·墨菲說，
identified overworked chemists giving out either the wrong medicine or the right medicines at the wrong dosages.
工作過度的化學家可開出錯誤的藥物，或者對正確的藥物開出了錯誤的劑量。
He listed cases of medicine-related fatalities: a woman in a Chesterfield care home given six times her prescribed dose of morphine by a Boots pharmacy;
他列舉了與藥物相關的死亡案例：一名婦女在切斯特菲爾德護理中心在博姿藥店被注射了六倍于她處方劑量的嗎啡；
a similar story in Weston-super-Mare; an 86-year-old widower in Felixstowe given the wrong drugs.
濱海威斯頓還有一例類似情況；費利克斯托的一位86歲的鰥夫服用了錯誤的藥物。
Boots rightly pointed out that such cases are very rare, stating that “patient safety is at the heart of what we do …
博姿適時地指出，這種情況非常罕見，并指出“患者的安全是我們工作的核心...
Whenever (such cases) happen our priority is always to the family … and working with the relevant investigators to seek to understand what happened”.
無論何時（這樣的案件）發生，我們的首要任務都是家屬...并與相關調查人員合作，試圖弄清楚到底發生了什么。”
Yet these incidents evidently play on the minds of Boots pharmacists.
然而，這些事件顯然引起了博姿藥劑師的注意。
